Author:
McKinnon Britt,Quach Caroline,Dubé Ève,Nguyen Cat Tuong,Zinszer Kate
Abstract
ABSTRACTBackgroundThe success of current and prospective COVID-19 vaccine campaigns for children and adolescents will in part depend on the willingness of parents to accept vaccination. This study examined social determinants of parental COVID-19 vaccine acceptance and uptake for children and adolescents.MethodsWe used cross-sectional data from an ongoing COVID-19 cohort study in Montreal, Canada and included all parents of 2 to 18-year-olds who completed an online questionnaire between May 18 and June 26, 2021 (n=809). We calculated child age-adjusted prevalence estimates of vaccine acceptance by parental education, race/ethnicity, birthplace, household income, and neighbourhood, and used multinomial logistic regression to estimate adjusted prevalence differences (aPD) and ratios (aPR). Social determinants of vaccine uptake were estimated for the vaccine-eligible sample of 12 to 18 year-olds (n=306).ResultsIntention to vaccinate children against COVID-19 was high, with only 12.4% of parents unlikely to have their child vaccinated. Parents with younger children were less likely to accept vaccination, as were those from lower-income households, racialized groups, and those born outside Canada. The percent of parents whose child was vaccinated or very likely to be vaccinated was 18.4 percentage points lower among those with annual household incomes <$100,000 vs. ≥$150,000 (95% CI: 10.1 to 26.7). Racialized parents reported greater unwillingness to vaccinate compared to White parents (aPD=10.3; 95% CI: 1.5, 19.1). Vaccine-eligible adolescents from the most deprived neighbourhood were half as likely to be vaccinated compared to those from the least deprived neighbourhood (aPR = 0.48; 95% CI: 0.18 to 0.77).InterpretationThis study identified marked social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents. Efforts are needed to reach disadvantaged and marginalized populations with tailored strategies that promote informed decision making and facilitate access to vaccination.
Publisher
Cold Spring Harbor Laboratory
Reference27 articles.
1. Gilmore R. Pfizer COVID-19 vaccine approved for Canadians 12 and over, Health Canada says. Global News. https://globalnews.ca/news/7835614/pfizer-covid-19-vaccine-approved-for-canadians-over-12-health-canada-says/. Published May 5, 2021.
2. Bahrampour T. The golden ticket for kids 11 and younger is a spot in a covid vaccine trial. Washington Post. https://www.washingtonpost.com/dc-md-va/2021/05/14/covid-vaccine-kids-under-12-trials/. Published May 14, 2021.
3. Coronavirus Disease 2019 and Vaccination of Children and Adolescents: Prospects and Challenges
4. Can COVID vaccines stop transmission? Scientists race to find answers
5. Public Health Agency of Canada. Update on COVID-19 in Canada: Epidemiology and Modelling.; 2021. https://www.canada.ca/content/dam/phac-aspc/documents/services/diseases-maladies/coronavirus-disease-covid-19/epidemiological-economic-research-data/update-covid-19-canada-epidemiology-modelling-20210326-en.pdf
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献